Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 13, 2023 02:02 ET | Source: Chr. Hansen Holding A/S

Chr. Hansen Holding A/S Interim Report Q2 2022/23

April 13, 2023 – Company announcement no. 6 A strong first half supporting the full-year outlook Statement by CEO Mauricio Graber: “The strong results for Q2 confirm the attractiveness of the...
March 30, 2023 12:07 ET | Source: Chr. Hansen Holding A/S

Novozymes’ and Chr. Hansen’s shareholders approve combination to create a leading global biosolutions partner

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART), IN OR INTO THE UNITED STATES, CANADA, SOUTH AFRICA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE SUCH...
March 30, 2023 11:58 ET | Source: Chr. Hansen Holding A/S

Resolutions passed at the Extraordinary General Meeting of Chr. Hansen Holding A/S

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART), IN OR INTO THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH ACTION WOULD BE UNLAWFUL. ...
March 30, 2023 07:11 ET | Source: Chr. Hansen Holding A/S

Combination between Novozymes and Chr. Hansen approved by Novozymes’ shareholders

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART), IN OR INTO THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH ACTION WOULD BE UNLAWFUL. MARCH 30,...
March 28, 2023 06:07 ET | Source: Chr. Hansen Holding A/S

Update on the combination of Novozymes and Chr. Hansen: U.S. antitrust regulation waiting period has expired, supporting the path to completion

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART), IN OR INTO THE UNITED STATES, CANADA, SOUTH AFRICA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE SUCH...
March 08, 2023 02:05 ET | Source: Chr. Hansen Holding A/S

Notice to convene Extraordinary General Meeting

MARCH 8, 2023 – ANNOUNCEMENT NO. 4 An Extraordinary General Meeting of Chr. Hansen Holding A/S will be held on Thursday, March 30, 2023, at 5:00 p.m. CEST at The Hangar – Clarion...
March 08, 2023 02:00 ET | Source: Chr. Hansen Holding A/S

Publication of exemption document in relation to the proposed combination of Chr. Hansen and Novozymes, confirmation of outlook for 2022/23 and proposed candidates to the Board of Directors of the combined company

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART), IN OR INTO THE UNITED STATES, CANADA, SOUTH AFRICA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE SUCH...
January 24, 2023 11:00 ET | Source: Chr. Hansen Holding A/S

Novozymes and Chr. Hansen receive binding tax ruling that the proposed merger can be completed as a tax-exempt merger

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART), IN OR INTO THE UNITED STATES, CANADA, SOUTH AFRICA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE SUCH...
January 12, 2023 02:03 ET | Source: Chr. Hansen Holding A/S

Chr. Hansen Holding A/S Interim Report Q1 2022/23

January 12, 2023 – Company announcement no. 1 Solid Q1 supports the outlook for 2022/23 Statement by CEO Mauricio Graber: “The solid results for Q1 show the strength of our business model....
December 12, 2022 01:59 ET | Source: Chr. Hansen Holding A/S

Novozymes and Chr. Hansen to combine and create a leading global biosolutions partner

DECEMBER 12, 2022 – ANNOUNCEMENT NO. 13 Novozymes and Chr. Hansen have entered into an agreement to create a leading global biosolutions partner through a statutory merger of the two companies. The...